ArticleBasic research in cardiology2021

Preclinical trial of a MAP4K4 inhibitor to reduce infarct size in the pig: does cardioprotection in human stem cell-derived myocytes predict success in large mammals?

Maaike Te Lintel Hekkert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.